Drug Pipeline
Four new drugs to treat migraines as they are happening are approaching approval from the U.S. Food and Drug Administration. They pose potential relief for the 39 million... More
Feature
“Trend Management”
40 result(s)
Care Management
Payors can better manage oncology costs by optimizing therapy regimen selection using evidence-based guidelines directly integrated into our proprietary Novologix platform. More
Video
Cost Management
Payors are projected to save on per-member-per-month costs from strategic formulary removals designed to help mitigate the effect of high-cost and hyperinflationary drugs More
Briefing
Specialty
CVS Health uses its integrated model to manage specialty spend across benefits and help positively impact clinical and financial outcomes. More
Briefing
Public Policy
What Can Help Lower Drug Costs?
Our perspective offered to Congress on solutions and policies that can help bring escalating drug prices under control. More
Commentary
Cost Management
Epidiolex, the latest cannabis-based drug to be approved by the FDA to treat certain seizure disorders, is a highly potent form of cannabidiol. Given the narrow indication and... More
Feature
Cost Management
New CMS rule enables Medicare Part B Payors to use step therapy to direct patients to lower-cost, clinically appropriate medications first, giving them an opportunity to implement... More
Briefing
Cost Management
CVS Caremark’s QALY-based program aims to bring rationality to drug pricing using comparative effectiveness research and cost-effectiveness analysis, and get manufacturers to set... More
Commentary
Cost Management
CVS Health is proposing innovations that build on existing PBM techniques to help patients afford the medications they need and improving outcomes while lowering high drug maker... More
White Paper
Specialty
CVS Health’s three-tier specialty formulary design separates the increasingly more expensive specialty therapies into three distinct copay or coinsurance categories. Paired with... More
Briefing